Advantages and pitfalls of 18F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting locally residual or recurrent nasopharyngeal carcinoma: comparison with magnetic resonance imaging
Authors:
- 19 April 2006
- journal article
- clinical trial
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 33 (9) , 1032-1040
Abstract
This prospective study was designed to elucidate the advantages and pitfalls of 18F-FDG PET in detecting locally residual/recurrent nasopharyngeal carcinoma (NPC) in comparison with MRI. We recruited NPC patients from two ongoing prospective trials. One is being performed to evaluate suspected local recurrence (group A) and the other to assess local treatment response 3 months after therapy (group B). Both groups received 18F-FDG PET and head and neck MRI. The gold standard was histopathology or clinical/imaging follow-up. An optimal cut-off standardised uptake value (SUV) was retrospectively determined. From January 2002 to August 2004, 146 patients were eligible. Thirty-four were from group A and 112 from group B. In all, 26 had locally recurrent/residual tumours. Differences in detection rate between 18F-FDG PET and MRI were not statistically significant in either group. However, 18F-FDG PET showed significantly higher specificity than MRI in detecting residual tumours among patients with initial T4 disease (p=0.04). In contrast, the specificity of 18F-FDG PET for patients with an initial T1–2 tumour treated with intracavitary brachytherapy (ICBT) was significantly lower than that for patients not treated by ICBT (72.2% vs 98.1%, p=0.003). At an SUV cut-off of 4.2, PET showed an equal and a higher accuracy compared with MRI in groups A and B, respectively. 18F-FDG PET is superior to MRI in identifying locally residual NPC among patients with initial T4 disease but demonstrates limitations in assessing treatment response in patients with initial T1–2 disease after ICBT. A cut-off SUV is a useful index for aiding in the visual detection of locally residual/recurrent NPC.Keywords
This publication has 28 references indexed in Scilit:
- Treatment of nasopharyngeal carcinoma with intensity-modulated radiotherapy: The Hong Kong experienceInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- Recent perspectives in the role of chemotherapy in the management of advanced nasopharyngeal carcinomaCancer, 2004
- Reirradiation for locally recurrent nasopharyngeal carcinoma: Treatment results and prognostic factorsInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 2004
- 18‐Fluoro‐2‐deoxyglucose positron emission tomography in detecting residual/recurrent nasopharyngeal carcinomas and comparison with magnetic resonance imagingCancer, 2003
- Detection of recurrent nasopharyngeal carcinomas with positron emission tomography using 18-fluoro-2-deoxyglucose in patients with indeterminate magnetic resonance imaging findings after radiotherapyJournal of Cancer Research and Clinical Oncology, 2002
- Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with technetium‐99m methoxyisobutylisonitrile single photon emission computed tomography and computed tomographyCancer, 2002
- Improved local control for early T-stage nasopharyngeal carcinoma – a tale of two hospitalsRadiotherapy and Oncology, 2000
- Positron Emission Tomography With Fluorodeoxyglucose for Suspected Head and Neck Tumor Recurrence in the Symptomatic PatientThe Laryngoscope, 2000
- Invited. MRI of nasopharyngeal carcinoma with emphasis on relationship to radiotherapyJournal of Magnetic Resonance Imaging, 1998
- Staging and follow-up of nasopharyngeal carcinoma: Magnetic resonance imaging versus computerized tomographyInternational Journal of Radiation Oncology - Biology - Physics (IJROBP), 1995